nodes	percent_of_prediction	percent_of_DWPC	metapath
Pergolide—DRD2—nicotine dependence	0.63	1	CbGaD
Pergolide—Splenomegaly—Varenicline—nicotine dependence	0.00669	0.0357	CcSEcCtD
Pergolide—Facial paralysis—Varenicline—nicotine dependence	0.00584	0.0311	CcSEcCtD
Pergolide—Varicose vein—Varenicline—nicotine dependence	0.00499	0.0266	CcSEcCtD
Pergolide—VIIth nerve paralysis—Varenicline—nicotine dependence	0.00453	0.0241	CcSEcCtD
Pergolide—Aphthous stomatitis—Varenicline—nicotine dependence	0.00396	0.0211	CcSEcCtD
Pergolide—Myositis—Varenicline—nicotine dependence	0.00379	0.0202	CcSEcCtD
Pergolide—Hostility—Varenicline—nicotine dependence	0.00335	0.0179	CcSEcCtD
Pergolide—Osteoporosis—Varenicline—nicotine dependence	0.00331	0.0177	CcSEcCtD
Pergolide—Gastric ulcer—Varenicline—nicotine dependence	0.0032	0.017	CcSEcCtD
Pergolide—Vaginal discharge—Varenicline—nicotine dependence	0.00305	0.0163	CcSEcCtD
Pergolide—Libido increased—Varenicline—nicotine dependence	0.00305	0.0163	CcSEcCtD
Pergolide—Electrocardiogram abnormal—Varenicline—nicotine dependence	0.00283	0.0151	CcSEcCtD
Pergolide—Intestinal obstruction—Varenicline—nicotine dependence	0.00272	0.0145	CcSEcCtD
Pergolide—Paranoia—Varenicline—nicotine dependence	0.00272	0.0145	CcSEcCtD
Pergolide—Haematemesis—Varenicline—nicotine dependence	0.00267	0.0143	CcSEcCtD
Pergolide—Delusion—Varenicline—nicotine dependence	0.00262	0.014	CcSEcCtD
Pergolide—Cabergoline—DRD2—nicotine dependence	0.00261	0.599	CrCbGaD
Pergolide—Mania—Varenicline—nicotine dependence	0.00255	0.0136	CcSEcCtD
Pergolide—Menorrhagia—Varenicline—nicotine dependence	0.00251	0.0134	CcSEcCtD
Pergolide—Extrapyramidal disorder—Varenicline—nicotine dependence	0.00247	0.0131	CcSEcCtD
Pergolide—Scotoma—Varenicline—nicotine dependence	0.00245	0.013	CcSEcCtD
Pergolide—Gingivitis—Varenicline—nicotine dependence	0.00237	0.0126	CcSEcCtD
Pergolide—Nephrolithiasis—Varenicline—nicotine dependence	0.00231	0.0123	CcSEcCtD
Pergolide—Endocrine disorder—Varenicline—nicotine dependence	0.00224	0.0119	CcSEcCtD
Pergolide—Accidental injury—Varenicline—nicotine dependence	0.0021	0.0112	CcSEcCtD
Pergolide—Ventricular extrasystoles—Varenicline—nicotine dependence	0.00206	0.011	CcSEcCtD
Pergolide—DRD4—brain—nicotine dependence	0.00205	0.0569	CbGeAlD
Pergolide—Thinking abnormal—Varenicline—nicotine dependence	0.00203	0.0108	CcSEcCtD
Pergolide—Leukocytosis—Varenicline—nicotine dependence	0.00198	0.0105	CcSEcCtD
Pergolide—Coordination abnormal—Varenicline—nicotine dependence	0.00189	0.0101	CcSEcCtD
Pergolide—Pulmonary embolism—Varenicline—nicotine dependence	0.00186	0.0099	CcSEcCtD
Pergolide—Abnormal dreams—Varenicline—nicotine dependence	0.00184	0.00979	CcSEcCtD
Pergolide—Eructation—Varenicline—nicotine dependence	0.00182	0.00973	CcSEcCtD
Pergolide—Lisuride—DRD2—nicotine dependence	0.00175	0.401	CrCbGaD
Pergolide—Photophobia—Varenicline—nicotine dependence	0.00174	0.0093	CcSEcCtD
Pergolide—HTR1B—cardiovascular system—nicotine dependence	0.0017	0.0473	CbGeAlD
Pergolide—Oesophagitis—Varenicline—nicotine dependence	0.0017	0.00905	CcSEcCtD
Pergolide—HTR1D—cardiovascular system—nicotine dependence	0.00165	0.0458	CbGeAlD
Pergolide—DRD1—midbrain—nicotine dependence	0.00164	0.0455	CbGeAlD
Pergolide—Hypertonia—Varenicline—nicotine dependence	0.00163	0.00868	CcSEcCtD
Pergolide—Mental disability—Varenicline—nicotine dependence	0.00161	0.00859	CcSEcCtD
Pergolide—Euphoric mood—Varenicline—nicotine dependence	0.0016	0.00851	CcSEcCtD
Pergolide—Lymphadenopathy—Varenicline—nicotine dependence	0.00158	0.00842	CcSEcCtD
Pergolide—Diabetes mellitus—Varenicline—nicotine dependence	0.00155	0.00826	CcSEcCtD
Pergolide—HTR2B—cardiovascular system—nicotine dependence	0.00154	0.0426	CbGeAlD
Pergolide—Deafness—Varenicline—nicotine dependence	0.00151	0.00803	CcSEcCtD
Pergolide—Eczema—Varenicline—nicotine dependence	0.0015	0.008	CcSEcCtD
Pergolide—Eye pain—Varenicline—nicotine dependence	0.00149	0.00796	CcSEcCtD
Pergolide—Injury—Varenicline—nicotine dependence	0.00147	0.00782	CcSEcCtD
Pergolide—Libido decreased—Varenicline—nicotine dependence	0.00145	0.00775	CcSEcCtD
Pergolide—DRD3—brain—nicotine dependence	0.00144	0.04	CbGeAlD
Pergolide—Increased appetite—Varenicline—nicotine dependence	0.00143	0.00765	CcSEcCtD
Pergolide—Amnesia—Varenicline—nicotine dependence	0.00143	0.00765	CcSEcCtD
Pergolide—Atrial fibrillation—Varenicline—nicotine dependence	0.00142	0.00758	CcSEcCtD
Pergolide—Thirst—Varenicline—nicotine dependence	0.00142	0.00755	CcSEcCtD
Pergolide—Arthritis—Varenicline—nicotine dependence	0.00139	0.0074	CcSEcCtD
Pergolide—Hypoglycaemia—Varenicline—nicotine dependence	0.00138	0.00737	CcSEcCtD
Pergolide—HTR1A—cardiovascular system—nicotine dependence	0.00138	0.0381	CbGeAlD
Pergolide—Cerebrovascular accident—Varenicline—nicotine dependence	0.00138	0.00733	CcSEcCtD
Pergolide—DRD5—brain—nicotine dependence	0.00135	0.0375	CbGeAlD
Pergolide—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00134	0.00713	CcSEcCtD
Pergolide—HTR1B—midbrain—nicotine dependence	0.00133	0.0369	CbGeAlD
Pergolide—Migraine—Varenicline—nicotine dependence	0.00133	0.00707	CcSEcCtD
Pergolide—Affect lability—Varenicline—nicotine dependence	0.00133	0.00707	CcSEcCtD
Pergolide—Psychotic disorder—Varenicline—nicotine dependence	0.00132	0.00702	CcSEcCtD
Pergolide—HTR1D—midbrain—nicotine dependence	0.00129	0.0357	CbGeAlD
Pergolide—Urinary retention—Varenicline—nicotine dependence	0.00128	0.00683	CcSEcCtD
Pergolide—Mood swings—Varenicline—nicotine dependence	0.00128	0.00681	CcSEcCtD
Pergolide—HTR2C—midbrain—nicotine dependence	0.00128	0.0354	CbGeAlD
Pergolide—ADRA1A—cardiovascular system—nicotine dependence	0.00127	0.0352	CbGeAlD
Pergolide—Liver function test abnormal—Varenicline—nicotine dependence	0.00124	0.00664	CcSEcCtD
Pergolide—Dry skin—Varenicline—nicotine dependence	0.00124	0.00659	CcSEcCtD
Pergolide—Hypokalaemia—Varenicline—nicotine dependence	0.00123	0.00654	CcSEcCtD
Pergolide—KCNH2—cardiovascular system—nicotine dependence	0.00122	0.034	CbGeAlD
Pergolide—Gastritis—Varenicline—nicotine dependence	0.00119	0.00636	CcSEcCtD
Pergolide—Abdominal distension—Varenicline—nicotine dependence	0.00117	0.00625	CcSEcCtD
Pergolide—Asthma—Varenicline—nicotine dependence	0.00117	0.00621	CcSEcCtD
Pergolide—Dysphagia—Varenicline—nicotine dependence	0.00117	0.00621	CcSEcCtD
Pergolide—Angina pectoris—Varenicline—nicotine dependence	0.00113	0.00605	CcSEcCtD
Pergolide—Bronchitis—Varenicline—nicotine dependence	0.00112	0.00597	CcSEcCtD
Pergolide—ADRA1B—brain—nicotine dependence	0.00111	0.0307	CbGeAlD
Pergolide—ADRA1D—brain—nicotine dependence	0.00108	0.03	CbGeAlD
Pergolide—Pollakiuria—Varenicline—nicotine dependence	0.00108	0.00574	CcSEcCtD
Pergolide—HTR1A—midbrain—nicotine dependence	0.00107	0.0298	CbGeAlD
Pergolide—Erectile dysfunction—Varenicline—nicotine dependence	0.00107	0.00572	CcSEcCtD
Pergolide—Weight increased—Varenicline—nicotine dependence	0.00106	0.00565	CcSEcCtD
Pergolide—Hyperglycaemia—Varenicline—nicotine dependence	0.00105	0.0056	CcSEcCtD
Pergolide—Depression—Varenicline—nicotine dependence	0.00104	0.00552	CcSEcCtD
Pergolide—DRD1—brain—nicotine dependence	0.00103	0.0286	CbGeAlD
Pergolide—Acute coronary syndrome—Varenicline—nicotine dependence	0.00102	0.00546	CcSEcCtD
Pergolide—Myocardial infarction—Varenicline—nicotine dependence	0.00102	0.00543	CcSEcCtD
Pergolide—Conjunctivitis—Varenicline—nicotine dependence	0.00101	0.00538	CcSEcCtD
Pergolide—Epistaxis—Varenicline—nicotine dependence	0.00098	0.00522	CcSEcCtD
Pergolide—Sinusitis—Varenicline—nicotine dependence	0.000975	0.0052	CcSEcCtD
Pergolide—DRD2—midbrain—nicotine dependence	0.000971	0.0269	CbGeAlD
Pergolide—KCNH2—midbrain—nicotine dependence	0.000956	0.0265	CbGeAlD
Pergolide—Bradycardia—Varenicline—nicotine dependence	0.000949	0.00506	CcSEcCtD
Pergolide—ADRA2C—midbrain—nicotine dependence	0.000944	0.0262	CbGeAlD
Pergolide—Hallucination—Varenicline—nicotine dependence	0.000928	0.00495	CcSEcCtD
Pergolide—Oedema peripheral—Varenicline—nicotine dependence	0.000919	0.0049	CcSEcCtD
Pergolide—Visual impairment—Varenicline—nicotine dependence	0.000899	0.00479	CcSEcCtD
Pergolide—Eye disorder—Varenicline—nicotine dependence	0.000871	0.00465	CcSEcCtD
Pergolide—Tinnitus—Varenicline—nicotine dependence	0.000869	0.00464	CcSEcCtD
Pergolide—Chills—Varenicline—nicotine dependence	0.000837	0.00446	CcSEcCtD
Pergolide—HTR1B—brain—nicotine dependence	0.000837	0.0232	CbGeAlD
Pergolide—Arrhythmia—Varenicline—nicotine dependence	0.000833	0.00444	CcSEcCtD
Pergolide—HTR2A—cardiovascular system—nicotine dependence	0.00082	0.0227	CbGeAlD
Pergolide—HTR1D—brain—nicotine dependence	0.00081	0.0225	CbGeAlD
Pergolide—HTR2C—brain—nicotine dependence	0.000802	0.0222	CbGeAlD
Pergolide—Flatulence—Varenicline—nicotine dependence	0.0008	0.00427	CcSEcCtD
Pergolide—Dysgeusia—Varenicline—nicotine dependence	0.000795	0.00424	CcSEcCtD
Pergolide—Back pain—Varenicline—nicotine dependence	0.000785	0.00419	CcSEcCtD
Pergolide—Tremor—Varenicline—nicotine dependence	0.000761	0.00406	CcSEcCtD
Pergolide—HTR2B—brain—nicotine dependence	0.000753	0.0209	CbGeAlD
Pergolide—Ill-defined disorder—Varenicline—nicotine dependence	0.000753	0.00402	CcSEcCtD
Pergolide—ADRA2A—midbrain—nicotine dependence	0.000753	0.0209	CbGeAlD
Pergolide—Anaemia—Varenicline—nicotine dependence	0.00075	0.004	CcSEcCtD
Pergolide—Agitation—Varenicline—nicotine dependence	0.000746	0.00398	CcSEcCtD
Pergolide—Malaise—Varenicline—nicotine dependence	0.000732	0.0039	CcSEcCtD
Pergolide—Vertigo—Varenicline—nicotine dependence	0.000729	0.00389	CcSEcCtD
Pergolide—Syncope—Varenicline—nicotine dependence	0.000728	0.00388	CcSEcCtD
Pergolide—Palpitations—Varenicline—nicotine dependence	0.000717	0.00383	CcSEcCtD
Pergolide—Loss of consciousness—Varenicline—nicotine dependence	0.000714	0.0038	CcSEcCtD
Pergolide—Cough—Varenicline—nicotine dependence	0.000708	0.00378	CcSEcCtD
Pergolide—Convulsion—Varenicline—nicotine dependence	0.000703	0.00375	CcSEcCtD
Pergolide—Hypertension—Varenicline—nicotine dependence	0.000701	0.00374	CcSEcCtD
Pergolide—Arthralgia—Varenicline—nicotine dependence	0.000691	0.00369	CcSEcCtD
Pergolide—Myalgia—Varenicline—nicotine dependence	0.000691	0.00369	CcSEcCtD
Pergolide—Chest pain—Varenicline—nicotine dependence	0.000691	0.00369	CcSEcCtD
Pergolide—Anxiety—Varenicline—nicotine dependence	0.000689	0.00367	CcSEcCtD
Pergolide—Discomfort—Varenicline—nicotine dependence	0.000683	0.00364	CcSEcCtD
Pergolide—Dry mouth—Varenicline—nicotine dependence	0.000676	0.0036	CcSEcCtD
Pergolide—HTR1A—brain—nicotine dependence	0.000675	0.0187	CbGeAlD
Pergolide—Oedema—Varenicline—nicotine dependence	0.000663	0.00353	CcSEcCtD
Pergolide—Infection—Varenicline—nicotine dependence	0.000658	0.00351	CcSEcCtD
Pergolide—Shock—Varenicline—nicotine dependence	0.000652	0.00348	CcSEcCtD
Pergolide—Thrombocytopenia—Varenicline—nicotine dependence	0.000649	0.00346	CcSEcCtD
Pergolide—Tachycardia—Varenicline—nicotine dependence	0.000647	0.00345	CcSEcCtD
Pergolide—Hyperhidrosis—Varenicline—nicotine dependence	0.00064	0.00342	CcSEcCtD
Pergolide—HTR2A—midbrain—nicotine dependence	0.00064	0.0177	CbGeAlD
Pergolide—Anorexia—Varenicline—nicotine dependence	0.000632	0.00337	CcSEcCtD
Pergolide—ADRA1A—brain—nicotine dependence	0.000622	0.0173	CbGeAlD
Pergolide—Hypotension—Varenicline—nicotine dependence	0.000619	0.0033	CcSEcCtD
Pergolide—DRD2—brain—nicotine dependence	0.00061	0.0169	CbGeAlD
Pergolide—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.000604	0.00322	CcSEcCtD
Pergolide—KCNH2—brain—nicotine dependence	0.000601	0.0167	CbGeAlD
Pergolide—Insomnia—Varenicline—nicotine dependence	0.000599	0.0032	CcSEcCtD
Pergolide—ADRA2C—brain—nicotine dependence	0.000593	0.0164	CbGeAlD
Pergolide—Dyspnoea—Varenicline—nicotine dependence	0.000591	0.00315	CcSEcCtD
Pergolide—Somnolence—Varenicline—nicotine dependence	0.000589	0.00314	CcSEcCtD
Pergolide—Dyspepsia—Varenicline—nicotine dependence	0.000583	0.00311	CcSEcCtD
Pergolide—Decreased appetite—Varenicline—nicotine dependence	0.000576	0.00307	CcSEcCtD
Pergolide—Pain—Varenicline—nicotine dependence	0.000567	0.00302	CcSEcCtD
Pergolide—Constipation—Varenicline—nicotine dependence	0.000567	0.00302	CcSEcCtD
Pergolide—Feeling abnormal—Varenicline—nicotine dependence	0.000546	0.00291	CcSEcCtD
Pergolide—Gastrointestinal pain—Varenicline—nicotine dependence	0.000542	0.00289	CcSEcCtD
Pergolide—Body temperature increased—Varenicline—nicotine dependence	0.000524	0.00279	CcSEcCtD
Pergolide—Abdominal pain—Varenicline—nicotine dependence	0.000524	0.00279	CcSEcCtD
Pergolide—Asthenia—Varenicline—nicotine dependence	0.000475	0.00253	CcSEcCtD
Pergolide—ADRA2A—brain—nicotine dependence	0.000473	0.0131	CbGeAlD
Pergolide—Pruritus—Varenicline—nicotine dependence	0.000469	0.0025	CcSEcCtD
Pergolide—Diarrhoea—Varenicline—nicotine dependence	0.000453	0.00242	CcSEcCtD
Pergolide—Dizziness—Varenicline—nicotine dependence	0.000438	0.00234	CcSEcCtD
Pergolide—Vomiting—Varenicline—nicotine dependence	0.000421	0.00225	CcSEcCtD
Pergolide—Rash—Varenicline—nicotine dependence	0.000418	0.00223	CcSEcCtD
Pergolide—Dermatitis—Varenicline—nicotine dependence	0.000417	0.00223	CcSEcCtD
Pergolide—Headache—Varenicline—nicotine dependence	0.000415	0.00221	CcSEcCtD
Pergolide—HTR2A—brain—nicotine dependence	0.000402	0.0112	CbGeAlD
Pergolide—Nausea—Varenicline—nicotine dependence	0.000394	0.0021	CcSEcCtD
Pergolide—CYP2D6—brain—nicotine dependence	0.000367	0.0102	CbGeAlD
Pergolide—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000132	0.000926	CbGpPWpGaD
Pergolide—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00013	0.000915	CbGpPWpGaD
Pergolide—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00013	0.000914	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—TAS2R16—nicotine dependence	0.00013	0.000913	CbGpPWpGaD
Pergolide—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000128	0.000901	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000128	0.0009	CbGpPWpGaD
Pergolide—HTR1A—GPCR downstream signaling—FGD1—nicotine dependence	0.000128	0.000898	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000128	0.000898	CbGpPWpGaD
Pergolide—HTR2C—GPCR downstream signaling—FGD1—nicotine dependence	0.000127	0.000893	CbGpPWpGaD
Pergolide—ADRA2B—GPCR ligand binding—OPRM1—nicotine dependence	0.000126	0.000884	CbGpPWpGaD
Pergolide—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000126	0.000881	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000125	0.000879	CbGpPWpGaD
Pergolide—ADRA2C—GPCR downstream signaling—FGD1—nicotine dependence	0.000124	0.000869	CbGpPWpGaD
Pergolide—ADRA1B—GPCR downstream signaling—FGD1—nicotine dependence	0.000122	0.000855	CbGpPWpGaD
Pergolide—HTR1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000122	0.000854	CbGpPWpGaD
Pergolide—HTR2C—GPCR ligand binding—OPRM1—nicotine dependence	0.000121	0.000849	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—FGD1—nicotine dependence	0.00012	0.000845	CbGpPWpGaD
Pergolide—DRD5—GPCR downstream signaling—OPRM1—nicotine dependence	0.00012	0.000844	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—FGD1—nicotine dependence	0.00012	0.000843	CbGpPWpGaD
Pergolide—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00012	0.00084	CbGpPWpGaD
Pergolide—HTR1D—GPCR ligand binding—DRD2—nicotine dependence	0.000118	0.000828	CbGpPWpGaD
Pergolide—ADRA2C—GPCR ligand binding—OPRM1—nicotine dependence	0.000118	0.000826	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—TAS2R16—nicotine dependence	0.000117	0.000823	CbGpPWpGaD
Pergolide—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000116	0.000817	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000116	0.000817	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—FGD1—nicotine dependence	0.000116	0.000816	CbGpPWpGaD
Pergolide—ADRA1B—GPCR ligand binding—OPRM1—nicotine dependence	0.000116	0.000813	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—FGD1—nicotine dependence	0.000116	0.000811	CbGpPWpGaD
Pergolide—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000116	0.000811	CbGpPWpGaD
Pergolide—HTR1B—GPCR ligand binding—DRD2—nicotine dependence	0.000115	0.00081	CbGpPWpGaD
Pergolide—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000115	0.000806	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—TAS2R16—nicotine dependence	0.000115	0.000806	CbGpPWpGaD
Pergolide—ADRA2A—G alpha (i) signalling events—DRD2—nicotine dependence	0.000114	0.000801	CbGpPWpGaD
Pergolide—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000114	0.0008	CbGpPWpGaD
Pergolide—DRD4—GPCR ligand binding—DRD2—nicotine dependence	0.000114	0.000797	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—TAS2R16—nicotine dependence	0.000113	0.000793	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—FGD1—nicotine dependence	0.000112	0.000789	CbGpPWpGaD
Pergolide—DRD2—GPCR downstream signaling—FGD1—nicotine dependence	0.000112	0.000789	CbGpPWpGaD
Pergolide—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000112	0.000784	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—FGD1—nicotine dependence	0.000111	0.000777	CbGpPWpGaD
Pergolide—HTR2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000111	0.000776	CbGpPWpGaD
Pergolide—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00011	0.000772	CbGpPWpGaD
Pergolide—DRD5—Signaling by GPCR—OPRM1—nicotine dependence	0.000109	0.000767	CbGpPWpGaD
Pergolide—HTR2B—GPCR ligand binding—DRD2—nicotine dependence	0.000108	0.000761	CbGpPWpGaD
Pergolide—ADRA1A—GPCR downstream signaling—FGD1—nicotine dependence	0.000108	0.00076	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—TAS2R16—nicotine dependence	0.000108	0.000757	CbGpPWpGaD
Pergolide—DRD2—GPCR ligand binding—OPRM1—nicotine dependence	0.000107	0.00075	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—AKR1B10—nicotine dependence	0.000106	0.000745	CbGpPWpGaD
Pergolide—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000106	0.000744	CbGpPWpGaD
Pergolide—HTR2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000105	0.000738	CbGpPWpGaD
Pergolide—ADRA1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000103	0.000722	CbGpPWpGaD
Pergolide—DRD1—GPCR ligand binding—DRD2—nicotine dependence	0.000102	0.000718	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—FGD1—nicotine dependence	0.000102	0.000716	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—TAS2R16—nicotine dependence	0.000102	0.000714	CbGpPWpGaD
Pergolide—ADRA1D—GPCR ligand binding—DRD2—nicotine dependence	0.000101	0.000708	CbGpPWpGaD
Pergolide—DRD3—GPCR ligand binding—DRD2—nicotine dependence	0.000101	0.000708	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000101	0.000706	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—FGD1—nicotine dependence	0.0001	0.000705	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—TAS2R16—nicotine dependence	0.0001	0.000704	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—TAS2R16—nicotine dependence	0.0001	0.000704	CbGpPWpGaD
Pergolide—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	9.98e-05	0.0007	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—FGD1—nicotine dependence	9.83e-05	0.00069	CbGpPWpGaD
Pergolide—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	9.77e-05	0.000686	CbGpPWpGaD
Pergolide—ADRA2A—GPCR ligand binding—OPRM1—nicotine dependence	9.56e-05	0.000671	CbGpPWpGaD
Pergolide—HTR1D—GPCR downstream signaling—OPRM1—nicotine dependence	9.22e-05	0.000647	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—FGD1—nicotine dependence	9.21e-05	0.000646	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—FGD1—nicotine dependence	9.14e-05	0.000641	CbGpPWpGaD
Pergolide—ADRA2B—GPCR ligand binding—DRD2—nicotine dependence	9.11e-05	0.000639	CbGpPWpGaD
Pergolide—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	9.08e-05	0.000637	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—TAS2R16—nicotine dependence	9.07e-05	0.000636	CbGpPWpGaD
Pergolide—HTR1B—GPCR downstream signaling—OPRM1—nicotine dependence	9.03e-05	0.000633	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—FGD1—nicotine dependence	9.01e-05	0.000632	CbGpPWpGaD
Pergolide—DRD4—GPCR downstream signaling—OPRM1—nicotine dependence	8.88e-05	0.000623	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—FGD1—nicotine dependence	8.87e-05	0.000622	CbGpPWpGaD
Pergolide—HTR1A—GPCR ligand binding—DRD2—nicotine dependence	8.8e-05	0.000617	CbGpPWpGaD
Pergolide—HTR2C—GPCR ligand binding—DRD2—nicotine dependence	8.75e-05	0.000614	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—TAS2R16—nicotine dependence	8.75e-05	0.000614	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—TAS2R16—nicotine dependence	8.71e-05	0.000611	CbGpPWpGaD
Pergolide—DRD5—GPCR downstream signaling—DRD2—nicotine dependence	8.7e-05	0.000611	CbGpPWpGaD
Pergolide—ADRA2C—GPCR ligand binding—DRD2—nicotine dependence	8.51e-05	0.000597	CbGpPWpGaD
Pergolide—HTR2B—GPCR downstream signaling—OPRM1—nicotine dependence	8.48e-05	0.000595	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—FGD1—nicotine dependence	8.47e-05	0.000594	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—TAS2R16—nicotine dependence	8.47e-05	0.000594	CbGpPWpGaD
Pergolide—ADRA1B—GPCR ligand binding—DRD2—nicotine dependence	8.38e-05	0.000588	CbGpPWpGaD
Pergolide—HTR1D—Signaling by GPCR—OPRM1—nicotine dependence	8.37e-05	0.000587	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—TAS2R16—nicotine dependence	8.33e-05	0.000585	CbGpPWpGaD
Pergolide—HTR1B—Signaling by GPCR—OPRM1—nicotine dependence	8.2e-05	0.000575	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—AKR1B10—nicotine dependence	8.13e-05	0.000571	CbGpPWpGaD
Pergolide—DRD4—Signaling by GPCR—OPRM1—nicotine dependence	8.07e-05	0.000566	CbGpPWpGaD
Pergolide—DRD1—GPCR downstream signaling—OPRM1—nicotine dependence	8e-05	0.000561	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—FGD1—nicotine dependence	7.99e-05	0.00056	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—AKR1B10—nicotine dependence	7.96e-05	0.000559	CbGpPWpGaD
Pergolide—DRD5—Signaling by GPCR—DRD2—nicotine dependence	7.9e-05	0.000554	CbGpPWpGaD
Pergolide—ADRA1D—GPCR downstream signaling—OPRM1—nicotine dependence	7.89e-05	0.000554	CbGpPWpGaD
Pergolide—DRD3—GPCR downstream signaling—OPRM1—nicotine dependence	7.89e-05	0.000554	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—FGD1—nicotine dependence	7.88e-05	0.000553	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—FGD1—nicotine dependence	7.88e-05	0.000553	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—AKR1B10—nicotine dependence	7.84e-05	0.00055	CbGpPWpGaD
Pergolide—HTR2B—Signaling by GPCR—OPRM1—nicotine dependence	7.7e-05	0.00054	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—TAS2R16—nicotine dependence	7.68e-05	0.000539	CbGpPWpGaD
Pergolide—HTR2A—GPCR ligand binding—DRD2—nicotine dependence	7.6e-05	0.000533	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—TAS2R16—nicotine dependence	7.56e-05	0.00053	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—AKR1B10—nicotine dependence	7.48e-05	0.000525	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—WASF2—nicotine dependence	7.48e-05	0.000525	CbGpPWpGaD
Pergolide—ADRA1A—GPCR ligand binding—DRD2—nicotine dependence	7.44e-05	0.000522	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—TAS2R16—nicotine dependence	7.4e-05	0.000519	CbGpPWpGaD
Pergolide—DRD1—Signaling by GPCR—OPRM1—nicotine dependence	7.26e-05	0.00051	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—WASF1—nicotine dependence	7.17e-05	0.000503	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—OPRM1—nicotine dependence	7.17e-05	0.000503	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—OPRM1—nicotine dependence	7.17e-05	0.000503	CbGpPWpGaD
Pergolide—ADRA2B—GPCR downstream signaling—OPRM1—nicotine dependence	7.12e-05	0.0005	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—FGD1—nicotine dependence	7.11e-05	0.000499	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—AKR1B10—nicotine dependence	7.05e-05	0.000495	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—AKR1B10—nicotine dependence	6.96e-05	0.000488	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—AKR1B10—nicotine dependence	6.96e-05	0.000488	CbGpPWpGaD
Pergolide—ADRA2A—GPCR ligand binding—DRD2—nicotine dependence	6.91e-05	0.000485	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—TAS2R16—nicotine dependence	6.88e-05	0.000483	CbGpPWpGaD
Pergolide—HTR1A—GPCR downstream signaling—OPRM1—nicotine dependence	6.88e-05	0.000482	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—FGD1—nicotine dependence	6.87e-05	0.000482	CbGpPWpGaD
Pergolide—HTR2C—GPCR downstream signaling—OPRM1—nicotine dependence	6.84e-05	0.00048	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—FGD1—nicotine dependence	6.83e-05	0.000479	CbGpPWpGaD
Pergolide—HTR1D—GPCR downstream signaling—DRD2—nicotine dependence	6.67e-05	0.000468	CbGpPWpGaD
Pergolide—ADRA2C—GPCR downstream signaling—OPRM1—nicotine dependence	6.65e-05	0.000467	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—FGD1—nicotine dependence	6.64e-05	0.000466	CbGpPWpGaD
Pergolide—ADRA1B—GPCR downstream signaling—OPRM1—nicotine dependence	6.55e-05	0.000459	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—FGD1—nicotine dependence	6.54e-05	0.000459	CbGpPWpGaD
Pergolide—HTR1B—GPCR downstream signaling—DRD2—nicotine dependence	6.53e-05	0.000458	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—CYP2A7—nicotine dependence	6.53e-05	0.000458	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—OPRM1—nicotine dependence	6.47e-05	0.000454	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—OPRM1—nicotine dependence	6.46e-05	0.000453	CbGpPWpGaD
Pergolide—DRD4—GPCR downstream signaling—DRD2—nicotine dependence	6.42e-05	0.000451	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—AKR1B10—nicotine dependence	6.28e-05	0.000441	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—OPRM1—nicotine dependence	6.24e-05	0.000438	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—OPRM1—nicotine dependence	6.21e-05	0.000436	CbGpPWpGaD
Pergolide—HTR2B—GPCR downstream signaling—DRD2—nicotine dependence	6.13e-05	0.00043	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—AKR1B10—nicotine dependence	6.07e-05	0.000426	CbGpPWpGaD
Pergolide—HTR1D—Signaling by GPCR—DRD2—nicotine dependence	6.05e-05	0.000425	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—OPRM1—nicotine dependence	6.04e-05	0.000424	CbGpPWpGaD
Pergolide—DRD2—GPCR downstream signaling—OPRM1—nicotine dependence	6.04e-05	0.000424	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—AKR1B10—nicotine dependence	6.03e-05	0.000423	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—FGD1—nicotine dependence	6.03e-05	0.000423	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—OPRM1—nicotine dependence	5.95e-05	0.000417	CbGpPWpGaD
Pergolide—HTR2A—GPCR downstream signaling—OPRM1—nicotine dependence	5.94e-05	0.000417	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—FGD1—nicotine dependence	5.93e-05	0.000416	CbGpPWpGaD
Pergolide—HTR1B—Signaling by GPCR—DRD2—nicotine dependence	5.93e-05	0.000416	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—AKR1B10—nicotine dependence	5.87e-05	0.000412	CbGpPWpGaD
Pergolide—DRD4—Signaling by GPCR—DRD2—nicotine dependence	5.83e-05	0.000409	CbGpPWpGaD
Pergolide—ADRA1A—GPCR downstream signaling—OPRM1—nicotine dependence	5.82e-05	0.000408	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—FGD1—nicotine dependence	5.81e-05	0.000408	CbGpPWpGaD
Pergolide—DRD1—GPCR downstream signaling—DRD2—nicotine dependence	5.78e-05	0.000406	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—AKR1B10—nicotine dependence	5.78e-05	0.000405	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—WASF2—nicotine dependence	5.73e-05	0.000402	CbGpPWpGaD
Pergolide—ADRA1D—GPCR downstream signaling—DRD2—nicotine dependence	5.7e-05	0.0004	CbGpPWpGaD
Pergolide—DRD3—GPCR downstream signaling—DRD2—nicotine dependence	5.7e-05	0.0004	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—WASF2—nicotine dependence	5.61e-05	0.000394	CbGpPWpGaD
Pergolide—HTR2B—Signaling by GPCR—DRD2—nicotine dependence	5.57e-05	0.000391	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—WASF2—nicotine dependence	5.52e-05	0.000387	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—WASF1—nicotine dependence	5.49e-05	0.000385	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—OPRM1—nicotine dependence	5.48e-05	0.000385	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—OPRM1—nicotine dependence	5.4e-05	0.000379	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—FGD1—nicotine dependence	5.4e-05	0.000379	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—OPRM1—nicotine dependence	5.4e-05	0.000379	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—WASF1—nicotine dependence	5.38e-05	0.000377	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—AKR1B10—nicotine dependence	5.33e-05	0.000374	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—CYP2A7—nicotine dependence	5.3e-05	0.000372	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—WASF1—nicotine dependence	5.29e-05	0.000371	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—OPRM1—nicotine dependence	5.28e-05	0.000371	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—WASF2—nicotine dependence	5.27e-05	0.00037	CbGpPWpGaD
Pergolide—DRD1—Signaling by GPCR—DRD2—nicotine dependence	5.25e-05	0.000368	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—AKR1B10—nicotine dependence	5.24e-05	0.000368	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—DRD2—nicotine dependence	5.18e-05	0.000363	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—DRD2—nicotine dependence	5.18e-05	0.000363	CbGpPWpGaD
Pergolide—ADRA2B—GPCR downstream signaling—DRD2—nicotine dependence	5.15e-05	0.000361	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—AKR1B10—nicotine dependence	5.13e-05	0.00036	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—WASF1—nicotine dependence	5.05e-05	0.000354	CbGpPWpGaD
Pergolide—HTR1A—GPCR downstream signaling—DRD2—nicotine dependence	4.97e-05	0.000349	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—WASF2—nicotine dependence	4.97e-05	0.000349	CbGpPWpGaD
Pergolide—HTR2C—GPCR downstream signaling—DRD2—nicotine dependence	4.95e-05	0.000347	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—OPRM1—nicotine dependence	4.95e-05	0.000347	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—OPRM1—nicotine dependence	4.91e-05	0.000344	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—WASF2—nicotine dependence	4.9e-05	0.000344	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—WASF2—nicotine dependence	4.9e-05	0.000344	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—OPRM1—nicotine dependence	4.84e-05	0.00034	CbGpPWpGaD
Pergolide—ADRA2C—GPCR downstream signaling—DRD2—nicotine dependence	4.81e-05	0.000338	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—AKR1B10—nicotine dependence	4.77e-05	0.000334	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—OPRM1—nicotine dependence	4.77e-05	0.000334	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—WASF1—nicotine dependence	4.76e-05	0.000334	CbGpPWpGaD
Pergolide—ADRA1B—GPCR downstream signaling—DRD2—nicotine dependence	4.73e-05	0.000332	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—WASF1—nicotine dependence	4.7e-05	0.00033	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—WASF1—nicotine dependence	4.7e-05	0.00033	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—DRD2—nicotine dependence	4.68e-05	0.000328	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—DRD2—nicotine dependence	4.67e-05	0.000328	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—OPRM1—nicotine dependence	4.55e-05	0.000319	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—DRD2—nicotine dependence	4.51e-05	0.000317	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—DRD2—nicotine dependence	4.49e-05	0.000315	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—WASF2—nicotine dependence	4.43e-05	0.000311	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—DRD2—nicotine dependence	4.37e-05	0.000307	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—DRD2—nicotine dependence	4.3e-05	0.000302	CbGpPWpGaD
Pergolide—HTR2A—GPCR downstream signaling—DRD2—nicotine dependence	4.3e-05	0.000301	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—OPRM1—nicotine dependence	4.29e-05	0.000301	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—WASF2—nicotine dependence	4.27e-05	0.0003	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—WASF2—nicotine dependence	4.25e-05	0.000298	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—WASF1—nicotine dependence	4.24e-05	0.000298	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—OPRM1—nicotine dependence	4.23e-05	0.000297	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—OPRM1—nicotine dependence	4.23e-05	0.000297	CbGpPWpGaD
Pergolide—ADRA1A—GPCR downstream signaling—DRD2—nicotine dependence	4.21e-05	0.000295	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—WASF2—nicotine dependence	4.14e-05	0.00029	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—WASF1—nicotine dependence	4.1e-05	0.000287	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—WASF1—nicotine dependence	4.08e-05	0.000286	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—WASF2—nicotine dependence	4.07e-05	0.000286	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—WASF1—nicotine dependence	3.96e-05	0.000278	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—DRD2—nicotine dependence	3.91e-05	0.000274	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—WASF1—nicotine dependence	3.9e-05	0.000274	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—DRD2—nicotine dependence	3.9e-05	0.000274	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—OPRM1—nicotine dependence	3.82e-05	0.000268	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—DRD2—nicotine dependence	3.82e-05	0.000268	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—WASF2—nicotine dependence	3.75e-05	0.000263	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—WASF2—nicotine dependence	3.69e-05	0.000259	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—OPRM1—nicotine dependence	3.69e-05	0.000259	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—OPRM1—nicotine dependence	3.67e-05	0.000257	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—WASF2—nicotine dependence	3.62e-05	0.000254	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—WASF1—nicotine dependence	3.6e-05	0.000252	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—DRD2—nicotine dependence	3.58e-05	0.000251	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—OPRM1—nicotine dependence	3.57e-05	0.00025	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—DRD2—nicotine dependence	3.55e-05	0.000249	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—WASF1—nicotine dependence	3.54e-05	0.000248	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—OPRM1—nicotine dependence	3.51e-05	0.000246	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—DRD2—nicotine dependence	3.5e-05	0.000246	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—WASF1—nicotine dependence	3.47e-05	0.000243	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—CYP2A7—nicotine dependence	3.45e-05	0.000242	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—DRD2—nicotine dependence	3.45e-05	0.000242	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—WASF2—nicotine dependence	3.36e-05	0.000236	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—DRD2—nicotine dependence	3.29e-05	0.000231	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—OPRM1—nicotine dependence	3.24e-05	0.000227	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—WASF1—nicotine dependence	3.22e-05	0.000226	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—OPRM1—nicotine dependence	3.19e-05	0.000224	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—OPRM1—nicotine dependence	3.12e-05	0.000219	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—DRD2—nicotine dependence	3.1e-05	0.000218	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—DRD2—nicotine dependence	3.06e-05	0.000215	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—DRD2—nicotine dependence	3.06e-05	0.000215	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—OPRM1—nicotine dependence	2.9e-05	0.000203	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—DRD2—nicotine dependence	2.76e-05	0.000194	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—DRD2—nicotine dependence	2.67e-05	0.000187	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—DRD2—nicotine dependence	2.65e-05	0.000186	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—DRD2—nicotine dependence	2.58e-05	0.000181	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—DRD2—nicotine dependence	2.54e-05	0.000178	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—DRD2—nicotine dependence	2.3e-05	0.000162	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—CYP2A7—nicotine dependence	2.26e-05	0.000158	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—DRD2—nicotine dependence	2.26e-05	0.000158	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—DRD2—nicotine dependence	2.1e-05	0.000147	CbGpPWpGaD
